Healthcare provider profile · identity verified

Michael H Ledbetter, DO

Family Medicine · CAMDENTON, MO · NPI 1477552479

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	676	181
Lisinopril	Lisinopril	597	156
Levothyroxine Sodium	Levothyroxine Sodium	558	139
Amlodipine Besylate	Amlodipine Besylate	536	141
Trazodone Hcl	Trazodone Hcl	498	129
Simvastatin	Simvastatin	492	116
Omeprazole	Omeprazole	462	132
Gabapentin	Gabapentin	384	92
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	365	66
Metoprolol Succinate	Metoprolol Succinate	345	95
Metformin Hcl	Metformin Hcl	335	93
Tramadol Hcl	Tramadol Hcl	329	72
Rosuvastatin Calcium	Rosuvastatin Calcium	328	94
Losartan Potassium	Losartan Potassium	321	76
Metoprolol Tartrate	Metoprolol Tartrate	296	69
Furosemide	Furosemide	295	82
Pantoprazole Sodium	Pantoprazole Sodium	267	76
Tamsulosin Hcl	Tamsulosin Hcl	251	76
Albuterol Sulfate Hfa	Albuterol Sulfate	236	60
Carvedilol	Carvedilol	233	61
Alprazolam	Alprazolam	218	52
Meloxicam	Meloxicam	218	57
Irbesartan	Irbesartan	183	47
Famotidine	Famotidine	173	52
Potassium Chloride	Potassium Chloride	171	45
Hydrochlorothiazide	Hydrochlorothiazide	156	46
Allopurinol	Allopurinol	148	40
Clopidogrel	Clopidogrel Bisulfate	132	34
Eliquis	Apixaban	129	30
Glipizide	Glipizide	115	33
Valsartan	Valsartan	115	34
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	104	16
Oxycodone Hcl	Oxycodone Hcl	100	19
Zolpidem Tartrate	Zolpidem Tartrate	89	30
Citalopram Hbr	Citalopram Hydrobromide	86	24
Clonazepam	Clonazepam	86	16
Sertraline Hcl	Sertraline Hcl	85	21
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	84	28
Propranolol Hcl	Propranolol Hcl	84	24
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	82	27
Lorazepam	Lorazepam	82	24
Pravastatin Sodium	Pravastatin Sodium	76	19
Fluticasone Propionate	Fluticasone Propionate	74	32
Clonidine Hcl	Clonidine Hcl	72	18
Triamcinolone Acetonide	Triamcinolone Acetonide	71	50
Donepezil Hcl	Donepezil Hcl	69	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	69	17
Sotalol	Sotalol Hcl	68	20
Prednisone	Prednisone	67	37
Warfarin Sodium	Warfarin Sodium	66	16
Quetiapine Fumarate	Quetiapine Fumarate	65	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	61	19
Trulicity	Dulaglutide	61	suppressed
Duloxetine Hcl	Duloxetine Hcl	60	16
Atenolol	Atenolol	58	13
Hydralazine Hcl	Hydralazine Hcl	57	16
Farxiga	Dapagliflozin Propanediol	55	13
Estradiol	Estradiol	54	19
Nifedipine Er	Nifedipine	54	15
Benazepril Hcl	Benazepril Hcl	53	16
Synthroid	Levothyroxine Sodium	53	16
Montelukast Sodium	Montelukast Sodium	52	13
Diazepam	Diazepam	50	12
Lovastatin	Lovastatin	50	16
Metformin Hcl Er	Metformin Hcl	49	12
Solifenacin Succinate	Solifenacin Succinate	48	13
Ropinirole Hcl	Ropinirole Hcl	46	14
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	12
Acetaminophen-Codeine	Acetaminophen With Codeine	44	suppressed
Flecainide Acetate	Flecainide Acetate	43	suppressed
Mirtazapine	Mirtazapine	43	suppressed
Memantine Hcl	Memantine Hcl	41	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	40	13
Olmesartan Medoxomil	Olmesartan Medoxomil	40	suppressed
Ventolin Hfa	Albuterol Sulfate	40	suppressed
Ibuprofen	Ibuprofen	39	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	39	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	11
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	38	12
Oxybutynin Chloride	Oxybutynin Chloride	38	suppressed
Xarelto	Rivaroxaban	35	suppressed
Finasteride	Finasteride	34	suppressed
Fenofibrate	Fenofibrate	33	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Celecoxib	Celecoxib	32	suppressed
Enalapril Maleate	Enalapril Maleate	32	suppressed
Spironolactone	Spironolactone	32	11
Symbicort	Budesonide/Formoterol Fumarate	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Myrbetriq	Mirabegron	30	suppressed
Temazepam	Temazepam	30	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	29	25
Ezetimibe	Ezetimibe	29	suppressed
Pregabalin	Pregabalin	29	suppressed
Breo Ellipta	Fluticasone/Vilanterol	28	suppressed
Chlorthalidone	Chlorthalidone	26	15
Glimepiride	Glimepiride	26	suppressed
Amiodarone Hcl	Amiodarone Hcl	25	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Ozempic	Semaglutide	24	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	22	suppressed
Buspirone Hcl	Buspirone Hcl	22	suppressed
Humulin N Kwikpen	Insulin Nph Human Isophane	22	suppressed
Novolin N Flexpen	Insulin Nph Human Isophane	22	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Acyclovir	Acyclovir	20	suppressed
Baclofen	Baclofen	20	suppressed
Digoxin	Digoxin	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	20	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	19	suppressed
Fentanyl	Fentanyl	19	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	19	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	19	suppressed
Morphine Sulfate Er	Morphine Sulfate	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Nystatin	Nystatin	17	11
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Colestipol Hcl	Colestipol Hcl	16	suppressed
Humulin 70/30 Kwikpen	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Klor-Con M20	Potassium Chloride	15	suppressed
Midodrine Hcl	Midodrine Hcl	15	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	14	14
Doxycycline Hyclate	Doxycycline Hyclate	14	11
Fluconazole	Fluconazole	14	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	14	suppressed
Spiriva Respimat	Tiotropium Bromide	14	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	14	suppressed
Cephalexin	Cephalexin	13	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Latanoprost	Latanoprost	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Imipramine Hcl	Imipramine Hcl	12	suppressed
Naproxen	Naproxen	12	suppressed
Premarin	Estrogens, Conjugated	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Tramadol Hcl Er	Tramadol Hcl	12	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Glyburide	Glyburide	11	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error